Self-reported Adherence to Treatment and Disease Activity in Patients with Rheumatoid Arthritis from Iran; Based on RHEUMATRY-RA Registry: A Cross-sectional Study
Authors:
- Mojtaba FazelMFMojtaba Fazel
- Peyvand Parhizkar RoudsariPRPeyvand Parhizkar Roudsari
- Alireza MirzamohamadiAMAlireza Mirzamohamadi
- Samaneh SoltaniSSSamaneh Soltani
- Marzieh AsgariMAMarzieh Asgari
- Mahdi MahmoudiMMMahdi Mahmoudi
- Ahmadreza JamshidiAJAhmadreza Jamshidi
- Maassoumeh AkhlaghiMAMaassoumeh Akhlaghi
- Elham MadresehEMElham Madreseh
Open Access
- 19 June 2025
- journal article
- Published by SAGE Publications in Indian Journal of Rheumatology
- Vol. 20 (3) , 253-262
Abstract
Background: Poor medication adherence challenges efficacy and costs in achieving treatment goals for rheumatoid arthritis (RA). This study aimed to determine the prevalence of treatment adherence and its related factors in Iranian RA patients. Methods: This cross-sectional study included RA outpatients referred to the rheumatology clinic of Shariati Hospital between March 2017 and September 2018, with the diagnosis based on the American College of Rheumatology (2010 ACR/EULAR) criteria. Treatment adherence was evaluated using the standardized Persian version of the 8-item Morisky Medication Adherence Scale (MMAS-8). Demographic and clinical information was extracted through the Iranian RA registry system (RHEUMATRY-RA). Results: Of 275 participants (222(81%) female), 20(7%) patients had active RA. Medication adherence was low in 138(50%) of patients, moderate in 81(30%) and high in 56(20%). In patients with disease duration ≤ 10 years, medication adherence was significantly associated with sex and occupation. It was observed that older patients (adjusted odds ratio (aOR) (95% confidence interval (CI): 1.01(0.98, 1.03)) and women (aOR (95% CI): 1.64(0.60, 4.45)) had more adherence. Patients on glucocorticoids demonstrated higher (aOR (95% CI): 1.76(0.81, 3.84)) and on methotrexate lower (aOR (95% CI): 0.58(0.18, 1.86)) adherence. The odds of disease activity were 21% lower in people who had adhered to medication (aOR (95% CI): 0.79(0.29, 2.15)). Conclusion: Despite the inherent complexity of adherence behaviors, this study identified a high prevalence of poor medication adherence among RA patients. Patients with better adherence may have lower disease activity, underscoring its role in effective disease management.Keywords
This publication has 31 references indexed in Scilit:
- Predictors of methotrexate adherence and patient's awareness of it in rheumatoid arthritis and its effect on quality of lifeJournal of Pharmaceutical Policy and Practice, 2024
- The pathogenesis of rheumatoid arthritisImmunity, 2022
- The Persian version of the 8-item Morisky Medication Adherence Scale (MMAS-8): can we trust it?Journal of Diabetes & Metabolic Disorders, 2022
- The immunology of rheumatoid arthritisNature Immunology, 2020
- Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritisClinical Rheumatology, 2020
- The etiology of rheumatoid arthritisJournal of Autoimmunity, 2020
- Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritisClinical Rheumatology, 2019
- Novel treatment strategies in rheumatoid arthritisThe Lancet, 2017
- Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-studyRheumatology International, 2017
- Relationship Between Medication Adherence, Disease Severity And Employment Status In Rheumatoid ArthritisValue in Health, 2015